Show simple item record

dc.contributor.authorTay, Rebecca
dc.contributor.authorAckermann, Christoph J
dc.contributor.authorCalifano, Raffaele
dc.date.accessioned2019-03-04T12:32:40Z
dc.date.available2019-03-04T12:32:40Z
dc.date.issued2018en
dc.identifier.citationTay RY, Ackermann CJ, Califano R. Immunotherapy in tyrosine kinase inhibitor-naive advanced epidermal growth factor receptor-mutant non-small cell lung cancer-driving down a precarious road in driver-mutated lung cancer. Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S377-S80.en
dc.identifier.pmid30705861en
dc.identifier.doi10.21037/tlcr.2018.09.16en
dc.identifier.urihttp://hdl.handle.net/10541/621545
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.21037/tlcr.2018.09.16en
dc.titleImmunotherapy in tyrosine kinase inhibitor-naive advanced epidermal growth factor receptor-mutant non-small cell lung cancer-driving down a precarious road in driver-mutated lung cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.journalTranslational Lung Cancer Researchen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record